Frontiers in Oncology · 2023 · 12 citations · 86 references
Cancer BiologyTumor BiologyTranscriptional RegulationCancer Cell BiologyTumor TypesRadiation OncologyMolecular OncologyCancer ResearchDifferent Signaling PathwaysMedicineCancer GeneticsMicrorna DetectionEpigenetic RegulationCell BiologyTumor MicroenvironmentLung CancerCancer GenomicsBronchial NeoplasmSmall RnaTumor SuppressorSystems BiologyOncologyNon-coding Rna
Cancer has long been a topic of great interest in society and a major factor affecting human health. Breast, prostate, lung, and colorectal cancers are the top four tumor types with the greatest incidence rates in 2020, according to the most recent data on global cancer incidence. Among these, lung cancer had the highest fatality rate. Extensive research has shown that microRNAs, through different signaling pathways, play crucial roles in cancer development. It is considered that the PI3K/AKT signaling pathway plays a significant role in the development of lung cancer. MicroRNAs can act as a tumor suppressor or an oncogene by altering the expression of important proteins in this pathway, such as PTEN and AKT. In order to improve the clinical translational benefit of microRNAs in lung cancer research, we have generalized and summarized the way of action of microRNAs linked with the PI3/AKT signaling pathway in this review through literature search and data analysis.
86
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2022 · 17.9K citations · Full text
Epidemiology Of Cancer, Population Health Sciences, Cancer Registration +18
<i>EGFR</i> Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text
Tracking the Evolution of Non–Small-Cell Lung Cancer
Mariam Jamal‐Hanjani, Gareth A. Wilson, Nicholas McGranahan et al. · New England Journal of Medicine · 2017 · 2.3K citations · Full text